Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Medical and surgical treatment for ocular myasthenia.

Benatar M, Kaminski H.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD005081. doi: 10.1002/14651858.CD005081.pub3. Review.

PMID:
23235620
2.

Medical and surgical treatment for ocular myasthenia.

Benatar M, Kaminski H.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005081. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD005081.

PMID:
16625623
3.

Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Benatar M, Kaminski HJ; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2007 Jun 12;68(24):2144-9. Epub 2007 Apr 25. Review.

PMID:
17460154
4.

Acetylcholinesterase inhibitor treatment for myasthenia gravis.

Mehndiratta MM, Pandey S, Kuntzer T.

Cochrane Database Syst Rev. 2014 Oct 13;(10):CD006986. doi: 10.1002/14651858.CD006986.pub3. Review.

PMID:
25310725
5.

Acetylcholinesterase inhibitor treatment for myasthenia gravis.

Mehndiratta MM, Pandey S, Kuntzer T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006986. doi: 10.1002/14651858.CD006986.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD006986.

PMID:
21328290
6.

Corticosteroids for myasthenia gravis.

Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002828. Review.

PMID:
15846640
7.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka KV.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002277. doi: 10.1002/14651858.CD002277.pub4. Review.

PMID:
23235588
8.

Thymectomy for non-thymomatous myasthenia gravis.

Cea G, Benatar M, Verdugo RJ, Salinas RA.

Cochrane Database Syst Rev. 2013 Oct 14;(10):CD008111. doi: 10.1002/14651858.CD008111.pub2. Review.

PMID:
24122674
9.

Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Vrinten C, van der Zwaag AM, Weinreich SS, Scholten RJ, Verschuuren JJ.

Cochrane Database Syst Rev. 2014 Dec 17;(12):CD010028. doi: 10.1002/14651858.CD010028.pub2. Review.

PMID:
25515947
10.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
11.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2003;(2):CD002277. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002277.

PMID:
12804431
12.

Plasma exchange for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2002;(4):CD002275. Review.

PMID:
12519572
13.

Development of generalized disease at 2 years in patients with ocular myasthenia gravis.

Kupersmith MJ, Latkany R, Homel P.

Arch Neurol. 2003 Feb;60(2):243-8.

PMID:
12580710
14.

Acupuncture for Bell's palsy.

Chen N, Zhou M, He L, Zhou D, Li N.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD002914. doi: 10.1002/14651858.CD002914.pub5. Review.

PMID:
20687071
15.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
16.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
17.

Treatment for Lambert-Eaton myasthenic syndrome.

Keogh M, Sedehizadeh S, Maddison P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD003279. doi: 10.1002/14651858.CD003279.pub3. Review.

PMID:
21328260
18.

Natalizumab for induction of remission in Crohn's disease.

Macdonald JK, McDonald JW.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006097. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD006097.

PMID:
16856112
19.

Mistletoe therapy in oncology.

Horneber MA, Bueschel G, Huber R, Linde K, Rostock M.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003297. doi: 10.1002/14651858.CD003297.pub2. Review.

PMID:
18425885
20.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774

Supplemental Content

Support Center